# A Study to Evaluate the Efficacy and Safety of AK120 in the Treatment of Subjects With Moderate-to-severe Asthma

> **NCT05155020** · PHASE2 · TERMINATED · sponsor: **Akeso** · enrollment: 1 (actual)

## Conditions studied

- Asthma

## Interventions

- **BIOLOGICAL:** AK120
- **BIOLOGICAL:** AK120
- **BIOLOGICAL:** AK120
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT05155020
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-02-11
- **Primary completion:** 2022-08-05
- **Final completion:** 2022-08-05
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** The clinical development strategy has been changed
- **Last updated:** 2022-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05155020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05155020, "A Study to Evaluate the Efficacy and Safety of AK120 in the Treatment of Subjects With Moderate-to-severe Asthma". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT05155020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*